No matter the reason, its crucial to consult with a healthcare provider before making any changes to your medication regimen
Discuss the possibility of losing facial fat
Common combinations include Epithalon with CJC/Ipamorelin for patients targeting both sleep and body composition, Epithalon with GHK-Cu for patients focused on cellular repair and skin quality alongside longevity support, and Epithalon with MOTS-c for patients on metabolic and mitochondrial optimization protocols
Because these findings are largely based on laboratory and animal studies, expected outcomes in humans are uncertain and may vary by individual, dose, and the underlying condition
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes, administered as a once-weekly subcutaneous injection
Competitor data indicates that patients typically lose 5% of their initial body weight on average, and this can increase to over 10% within three months of use